The effect of the drug/polymer ratio on the properties of the verapamil HCl loaded microspheres

被引:107
作者
Kiliçarslan, M [1 ]
Baykara, T [1 ]
机构
[1] Ankara Univ, Fac Pharm, Dept Pharmaceut Technol, TR-06100 Ankara, Turkey
关键词
verapamil HCl; Eudragit RS 100; microsphere; solvent evaporation method;
D O I
10.1016/S0378-5173(02)00630-0
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
In this study, the microspheres containing verapamil hydrochloride (VRP) were prepared with Eudragit RS 100 by solvent evaporation method. In the solvent evaporation method one of the parameters which affect to the formation and properties of the microspheres is the variations of drug/polymer ratios. The aim of our study is to examine the effects of this parameter on the VRP loaded microspheres. To achieve this purpose, only drug/polymer ratio was altered while the other formulation parameters were kept constant and percentage yield value, incorporation efficiency, particle size and distribution of the microspheres were analyzed and micrographs of the microspheres were taken to determine the effects of the increase in the polymer amount of formulations. All the dispersed phase viscosities were evaluated by comparing them with the variations in particle size and distribution of the microspheres. In vitro dissolution tests were done by using dissolution media with three different pH in sequence as half-change method with flow through cell and the effect of the variation in polymer ratio on drug dissolution was evaluated according to dissolution test results. As a result of our study, it is thought that the variation in drug/polymer ratios might have an influence on the physical characteristics of the microspheres and the increasing amount of polymer might be result in decreased drug dissolve. (C) 2002 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:99 / 109
页数:11
相关论文
共 35 条
[21]  
LUNDEN MT, 1991, CLIN PHARM, V20, P429
[22]   CONTROLLED RELEASE INDOMETHACIN MICROSPHERES PREPARED BY USING AN EMULSION SOLVENT-DIFFUSION TECHNIQUE [J].
MALAMATARIS, S ;
AVGERINOS, A .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1990, 62 (2-3) :105-111
[23]   PHARMACOKINETICS OF SUSTAINED-RELEASE VERAPAMIL AFTER A SINGLE ADMINISTRATION AND AT STEADY-STATE [J].
MATTILA, J ;
MANTYLA, R ;
TASKINEN, J ;
MANNISTO, P .
EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 1985, 10 (02) :133-138
[24]   VERAPAMIL - AN UPDATED REVIEW OF ITS PHARMACODYNAMIC AND PHARMACOKINETIC PROPERTIES, AND THERAPEUTIC USE IN HYPERTENSION [J].
MCTAVISH, D ;
SORKIN, EM .
DRUGS, 1989, 38 (01) :19-76
[25]  
MURTHY JS, 1994, MULTIPARTICULATE ORA, P405
[26]   PREPARATION AND EVALUATION OF CONTROLLED RELEASE INDOMETHACIN MICROSPHERES [J].
PONGPAIBUL, Y ;
PRICE, JC ;
WHITWORTH, CW .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1984, 10 (10) :1597-1616
[27]   PREPARATION AND INVITRO DISSOLUTION CHARACTERISTICS OF PROPRANOLOL MICROCAPSULES [J].
PONGPAIBUL, Y ;
WHITWORTH, CW .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1986, 33 (1-3) :243-248
[28]  
RAWLE AF, 1993, MRK12502
[29]   Development of hollow microspheres as floating controlled-release systems for cardiovascular drugs: Preparation and release characteristics [J].
Soppimath, KS ;
Kulkarni, AR ;
Aminabhavi, TM .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2001, 27 (06) :507-515
[30]  
Thies C., 1992, MICROCAPSULES NANOPA, P47